蒋莉 - 同济大学 - 上海国际知识产权学院

个人简介

教育经历 2009年9月－2014年12月英国Bangor University法学博士 2006年9月－2009年7月山东大学法律硕士 2002年9月－2006年7月北京科技大学生物技术理学学士主要工作经历 2019年5月-今，同济大学上海国际知识产权学院，副教授 2015年5月-2019年4月，苏州大学王健法学院，讲师教学经历开设知识产权法、International Intellectual Property Law (英文)、专利法、专利实务等课程海外经历 2009年9月-2014年12月，英国班戈大学攻读博士学位所获证书和荣誉 2017年获江苏省知识产权骨干人才 2016年获专利代理人资格 2009年获国家留学基金委资助攻读博士学位 2009年获得班戈大学125 周年奖学金、法学院奖学金 2008年获法律执业资格

研究领域

专利法、生物技术法、医药卫生法

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

著作 Li Jiang, Regulating Human Embryonic Stem Cell in China- A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU, (2016), Springer （施普林格出版社）论文 Li Jiang, “Commercialization of the gene-edited crop and morality: challenges from liberal patent law and strict GMO law in the EU” (2019) New Genetic and Society (SSCI 三区) (forthcoming) Li Jiang，“Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent” (2018) Science and Engineering Ethic (SSCI二区) https://link.springer.com/article/10.1007%2Fs11948-018-0043-3 Li Jiang and Achim Rosemann，“Human embryo gene editing in China: the uncertain legal status of the embryo”（2018）BioSocieties (SSCI三区) https://link.springer.com/article/10.1057%2Fs41292-018-0116-1 Li Jiang，“Centralised Intellectual Property Administrative Management Reform in China: Why it is needed and whether it works” (2018) 111 Intellectual Property Forum 19-24 蒋莉，《基因编辑和人类生殖：社会伦理和法律规制》,《苏州大学学报法学版》，2018年第4期蒋莉，《人类基因编辑应有法可依》，载《中国社会科学报》2018年2月7日第1390期。 Achim Rosemann, Xin Qing Zhang and Li Jiang,“Human Germ Line Gene Editing: Why Comparative, Cross-National Studies of Public Viewpoints are Important” (2017) 5 Anthropology 175-178. Li Jiang and Bing He Dong，“Fraudsters Operate and Officialdom Turns a Blind Eye: a Proposal for Controlling Stem Cell Therapy in China” (2016) 19 Medicine, Health Care and Philosophy 403-410. (SSCI 二区) Li Jiang , “Will Wild East End Scientific Feast-the First Administrative Measure on Clinical Stem Cell Research in China” (2016) 35 Biotechnology Law Report 27-35. （SCI） Li Jiang , “Will Diversity Regulations Disadvantage Human Embryonic Stem Cell Research: a Comparison between EU and US” (2014) 25 Depaul Journal of Art, Technology and Intellectual Property Law 53-90. Li Jiang , “Between Scylla and Charybdis: Patentability And Morality Related To Human Embryonic Stem Cells”（2015）6 American University Intellectual Property Brief 53-97. Li Jiang and Wei Shi, “Space for Flexibility: Lessons from the European Union Harmonization Model in Human Embryonic Stem Cell Regulation” (2014) 97 Intellectual Property Forum 63-68. 书的章节 Li Jiang, “The Regulation of Genome Editing Technologies and New Methods of Germline Interventions in China” in Jochen Taupitz and Deuring Silvia (ed.)Rechtliche Aspekte der Genom-Editierung an der menschlichen Keimbahn, Springer (2019) Li Jiang，“The Regulation of Clinical Stem Cell in China” in Phuc Pham & Achim Rosemann (ed.), Stem Cells in Clinical Application: Safety, Ethics and Regulation, Springer (2017) Li Jiang,　“Patentability of Human Embryo Stem Cell: A Comparative Analyse of Case WARF in United States and Europe” in H. B. Singh, A. Jha and C. Keswani (ed.), Intellectual Property Issues in Biotechnology, CABI (2016) 咨询报告 2017年，Nuffield Bioethics Committee（英国纳菲尔德生物伦理委员会）， Achim Rosemann, Li Jiang and Xing Qing Zhang, The Regulatory and Legal Situation of Human Embryo, Gamete and Germ Line Gene Editing Research and Clinical Applications in the People’s Republic of China,

学术兼职

Asia Pacific Law Review （SSCI）审稿人